Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.

Devadason SG, Chan HK, Haeussermann S, Kietzig C, Kuehl PJ, Newman S, Sommerer K, Taylor G.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S6-9. doi: 10.1089/jamp.2012.1Su3.

PMID:
23215848
2.

Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.

Newman S, Bennett WD, Biddiscombe M, Devadason SG, Dolovich MB, Fleming J, Haeussermann S, Kietzig C, Kuehl PJ, Laube BL, Sommerer K, Taylor G, Usmani OS, Zeman KL.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S10-28. doi: 10.1089/jamp.2012.1Su4.

PMID:
23215844
3.

In vitro/in vivo comparisons in pulmonary drug delivery.

Newman SP, Chan HK.

J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):77-84. doi: 10.1089/jamp.2007.0643. Review.

PMID:
18518834
5.
6.

Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products.

Fleming J, Bailey DL, Chan HK, Conway J, Kuehl PJ, Laube BL, Newman S.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S29-51. doi: 10.1089/jamp.2012.1Su5.

PMID:
23215845
7.

Positron emission tomography (PET) for assessing aerosol deposition of orally inhaled drug products.

Dolovich MB, Bailey DL.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S52-71. doi: 10.1089/jamp.2012.1Su6.

PMID:
23215847
8.

Deposition, imaging, and clearance: what remains to be done?

Scheuch G, Bennett W, Borgström L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, O'Callaghan C, Taylor G, Newman S.

J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S39-57. doi: 10.1089/jamp.2010.0839. Review.

PMID:
21133799
9.

Introduction: Aerosol delivery of orally inhaled agents.

Corcoran TE, Devadason SG, Kuehl PJ.

J Aerosol Med Pulm Drug Deliv. 2012 Dec;25 Suppl 1:S3-5. doi: 10.1089/jamp.2012.1Su2.

10.

Pulmonary drug delivery by powder aerosols.

Yang MY, Chan JG, Chan HK.

J Control Release. 2014 Nov 10;193:228-40. doi: 10.1016/j.jconrel.2014.04.055. Epub 2014 May 9. Review.

PMID:
24818765
11.

Assessment methods of inhaled aerosols: technical aspects and applications.

Jaafar-Maalej C, Andrieu V, Elaissari A, Fessi H.

Expert Opin Drug Deliv. 2009 Sep;6(9):941-59. doi: 10.1517/17425240903117244.

PMID:
19637979
12.

Breath-synchronized plume-control inhaler for pulmonary delivery of fluticasone propionate.

Shrewsbury SB, Armer TA, Newman SP, Pitcairn G.

Int J Pharm. 2008 May 22;356(1-2):137-43. doi: 10.1016/j.ijpharm.2008.01.011. Epub 2008 Jan 17.

PMID:
18289809
13.

Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.

Christopher D, Adams W, Amann A, Bertha C, Byron PR, Doub W, Dunbar C, Hauck W, Lyapustina S, Mitchell J, Morgan B, Nichols S, Pan Z, Singh GJ, Tougas T, Tsong Y, Wolff R, Wyka B.

AAPS PharmSciTech. 2007 Nov 2;8(4):E90. doi: 10.1208/pt0804090.

14.
15.

Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.

Fazzi P, Borsò E, Albertelli R, Mariani G, Giuntini C.

Q J Nucl Med Mol Imaging. 2009 Aug;53(4):428-36. Epub 2009 Jan 28.

16.

The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.

Roberts DL, Mitchell JP.

AAPS PharmSciTech. 2013 Jun;14(2):497-510. doi: 10.1208/s12249-013-9936-2. Epub 2013 Mar 19.

17.

Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.

Glover W, Chan HK, Eberl S, Daviskas E, Verschuer J.

Int J Pharm. 2008 Feb 12;349(1-2):314-22. Epub 2007 Aug 19.

PMID:
17904774
18.

Influence of particle size on regional lung deposition--what evidence is there?

Carvalho TC, Peters JI, Williams RO 3rd.

Int J Pharm. 2011 Mar 15;406(1-2):1-10. doi: 10.1016/j.ijpharm.2010.12.040. Epub 2011 Jan 11. Review.

PMID:
21232585
19.

In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.

Mitchell J, Newman S, Chan HK.

AAPS PharmSciTech. 2007 Dec 21;8(4):E110. doi: 10.1208/pt0804110. Review.

Items per page

Supplemental Content

Write to the Help Desk